An examination of deoxyadenosine 5'(α-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor

British Journal of Pharmacology

Volumn 121, Issue 2, 1997, Pages 338-344

  Schachter, Joel B ^a   Harden, T Kendall ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

ATP; dATP S; Human P2Y1 receptor; Inositol phosphates; P2 receptor; Radioligand binding

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE DERIVATIVE; DEOXYADENOSINE TRIPHOSPHATE; INOSITOL PHOSPHATE; LIGAND; MEMBRANE RECEPTOR; PHOSPHOLIPASE C; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; RECOMBINANT PROTEIN; SULFUR 35; TRITIUM;

ANIMAL CELL; ARTICLE; ASTROCYTOMA CELL; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN; HUMAN CELL; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY;

EID: 0030894491     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701136     Document Type: Article

References (21)

1. AKBAR, G.K.M., DASARI, V.R., WEBB, T.E., AYYANATHAN, K., PILLARISETTI, K., SANDHU, A.K., ATHWAL, R.S., DANIEL, J.L., ASHBY, B., BARNARD, E.A. & KUNAPULI, S.P. (1996). Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells. J. Biol. Chem., 271, 18363-18367.
2. BERRIDGE, M.J., DAWSON, R.M.C., DOWNES, C.P., HESLOP, J.P. & IRVINE, R.F. (1983). Changes in the level of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J., 212, 473-482.
3. 2Y-purinergic receptor that inhibits adenylyl cyclase. J. Pharmacol. Exp. Ther., 267, 1140-1146.
4. 2Y-purinergic receptors. Br. J. Pharmacol., 113, 614-620.
5. 1 receptor. Mol. Pharmacol., 50, 1323-1329.
6. 2-purinoceptors? Gen. Pharmacol., 16, 433-440.
7. CHEN, C. & OKAYAMA, H. (1987). High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7, 2745-2752.
8. 2-purinergic receptor. J. Biol. Chem., 264, 6202-6206.
9. 2Y-purinoceptor agonists: structure activity relationships for 2-thioether derivatives of adenosine-5′-triphosphate. J. Med. Chem., 36, 3937-3946.
10. 2-purinergic receptors: subtype-associated signaling responses and structure. Annu. Rev. Pharmacol. Toxicol., 35, 541-579.
11. KAPLAN, M.H., SMITH, D.I. & SUNDICK, R.S. (1993). Identification of a G protein coupled receptor induced in activated T cells. J. Immunol., 151, 628-636.
12. KEPPENS, S., VANDEKERCKHOVE, A. & DE WULF, H. (1990). Characterization of the purinoceptors present in rabbit and guinea pig liver. Eur. J. Pharmacol., 182, 149-153.
13. 2U-purinergic receptor. Potent activation by diadenosine tetraphosphate. Br. J. Pharmacol., 116, 1619-1627.
14. 2 receptors. Eur. J. Pharmacol., 307, 201-209.
15. SATTIN, A. & RALL, T.W. (1970). The effect of adenosine and adenine nucleotides on the cyclic adenosine 3′,5′-monophosphate content of guinea pig cerebral cortex slices. Mol. Pharmacol., 6, 13-23.
16. 2Y1 receptor. Br. J. Pharmacol., 118, 167-173.
17. SCHILD, H.O. (1947). The use of drug antagonists for the identification of classification of drugs. Br. J. Pharmacol. Chemother., 2, 251-258.
18. 2Y purinoceptor. Eur. J. Pharmacol., 291, 281-289.
19. 2Y purinoceptor in the brain. Pharmacol. Toxicol., 76, 302-307.
20. VALLEJO, A.I., BO, X. & BURNSTOCK, G. (1996). P2Y purinoceptors in gastric gland plasma membranes. Eur. J. Pharmacol., 312, 209-214.
21. 5. Biochem. Biophys. Res. Commun., 219, 105-110.